Spectral Medical Inc T.EDT

Quarterly on Schedule

[pm1861]

Hello all,

After reading the latest NR I am left feeling a bit disappointed.  While the release highlights the accomplishments ( and there are many), it did not provide any detail on the recent Arc deal.  Good that they will seek approval for additional sites for TIGRIS. Further, there seems to be some foreshadowing to another raise from the
company

"While the Company continues to maintain a low cost operating structure for its base business operations, it anticipates its operating costs to increase throughout 2022 as Spectral’s Tigris trial enrolment is expected to increase, combined with incremental costs associated with Dialco’s upcoming usability trial for DIMI and the increase in field resources for the marketing and commercialization activities of its RRT devices."

Hopefully it won't come to more dilution.  My conviction in this company is still strong. Just wanted a little bit more.

PM

[Gorf79]

PM, Your " conviction is that the company is still strong"? Good to hear. In the past several week they did this: 1) Landed the largest dialysis provider in Florida as a SAMI client! 2) Received an FDA Breakthrough Designation  for their for PMX Sepsis treatment. 3) Landed the U.S. Department of Veterans Affairs as a SAMI client. They are the largest single health network in

[RickyBobbyTO]

this was way more honest than last years blindsided financing. Everyone knows they need cash, let the chips fall as they may. Good speed and good luck. We are almost mid august so bankers are returning to their desks, let it be quick and painless.   

[RickyBobbyTO]

Godspeed* (autocorrect)